Compare funds
Evaluate funds side by side, to find the best fit for your investment goals.
The Fund aims to achieve a return on your investment, through a combination of capital growth and income on the Funds assets, which reflects the return of the STOXX Global Breakthrough Healthcare Index. The Share Class, via the Fund is passively managed, and aims to invest in equity securities (e.g. shares) that, so far as possible and practicable, make up the Index.
View fundThe Fund aims to achieve a return on your investment, through a combination of capital growth and income on the Funds assets, which reflects the return of the STOXX Global Breakthrough Healthcare Index. The Share Class, via the Fund is passively managed, and aims to invest in equity securities (e.g. shares) that, so far as possible and practicable, make up the Index.
View fundKey takeaways
The ETFs £DRDR and €2B78 track the same security, and so are effectively the same fund. However, £DRDR is traded in British pounds on the London Stock Exchange, while €2B78 is traded in euros on the Deutsche Börse Xetra.
Fund highlights
Fund name | iShares Healthcare Innovation | iShares Healthcare Innovation |
|---|---|---|
GBP | EUR | |
USD | USD | |
| Accumulating | Accumulating | |
Fund size | £860m | €1bn |
| 1.17 | 1.17 | |
Last price | £7.16 | €8.36 |
| 0.40% | 0.40% | |
Fund manager | BlackRock | BlackRock |
Benchmark | STOXX Global Breakthrough Healthcare Index | STOXX Global Breakthrough Healthcare Index |
Risk | ||
Ticker | £DRDR | €2B78 |
Primary listing | LSE | XETRA |
Documents | £DRDR Key Information Document | €2B78 Key Information Document |
Market data provided by CBOE Europe and Deutsche Börse.
Performance
CumulativeRolling yearsLump sum investment
£DRDR
€2B78
Past performance is no guarantee of future returns.
The “cumulative” calculation shows returns on a price basis (i.e. excluding dividends). If an instrument trades in a different currency from your home currency, currency fluctuations may affect returns. These instruments are traded in different currencies, and performance is shown in the instruments' trading currencies
Sector exposure
ChartTable
£DRDR
€2B78
Top holdings
Moderna
1.72%
Natera
1.62%
Roivant Sciences
1.61%
Illumina
1.59%
Guardant Health
1.57%
Genmab A/S
1.56%
AbbVie
1.55%
Lonza Group AG
1.54%
Abbott
1.53%
Other
85.71%
Moderna
1.72%
Natera
1.62%
Roivant Sciences
1.61%
Illumina
1.59%
Guardant Health
1.57%
Genmab A/S
1.56%
AbbVie
1.55%
Lonza Group AG
1.54%
Abbott
1.53%
Other
85.71%
Invest in £DRDR or €2B78 on Lightyear
Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.